Top compounds associated with response to NINL


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.14 6e-07
mRNA STF-31 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.16 1e-06
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.14 3e-06
Download CSV